Financial Daily from THE HINDU group of publications
Tuesday, May 11, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Standards & Benchmarks


US FDA inspects Aurobindo units

Our Bureau

Hyderabad , May 10

AUROBINDO Pharma Ltd, manufacturer of active pharmaceutical intermediaries, has announced that its two units on the outskirts of the city have gone through inspection by the officials of the US Food and Drug Administration.

The unit-2 (API facility) and unit-3 (formulations facility), have been inspected and a final report is awaited, the pharma major informed the bourses today.

More Stories on : Standards & Benchmarks | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Marks & Spencer gets ready for sourcing base in Bangalore

Paradeep Carbon to supply coke to Nalco
Reliance Clinical looks to tap US, Europe markets
Kerala State Beverages Corp denies allegations
BEL retains rating for debt programme
Essel Propack commissions caps unit in US
BILT plans Rs 500-cr capacity expansion
Get Google's email — for a price
US FDA inspects Aurobindo units
IDBI cuts interest rates on loans for SCML
LeasePlan on growth path; to enter fuel management
Ashok Leyland sales double in April
Indo-Count net profit up 400 per cent
J.S. Javali is HMT Machine Tools CMD

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line